PATENT CLAIM ANALYSIS

Application Number: 16198645
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "254070"]

Abstract:
The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.

Claim (Index 31):
An oral pharmaceutical composition comprising about 50 mg or more to less than about 100 mg of itraconazole and one or more pharmaceutically acceptable polymers in a matrix system, wherein the composition exhibits an AUC 0-t  that is 80% to 125% of about 440 h*ng/ml to about 1200 h*ng/ml following administration of the composition to a subject under fed conditions.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14882662', '14511420', '15245105', '13473563', '11763578']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7683343079252287
- 35 USC 102 Novelty (BERT): 0.7456161969646198
- Combined Prediction Score: 0.7660624968291679
- Mean Citation Score: 583.3486379999998
- Max Citation Score: 926.78815
- Similarity Product: 833.9986654240877

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test